93 Chapter 4 15. Persiani P, Pesce M V., Martini L, et al. Intraoperative bleeding in patients with osteogenesis imperfecta type III treated by Fassier–Duval femoral rodding: analysis of risk factors. Journal of Pediatric Orthopaedics B 2017; : 1. 16. Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: In: Evaluation of chemotherapeutic agents. MacLeod CM, editor. New York: Columbia University Press; 1949. The clinical evaluation of chemotherapeutic agents in cancer; 1948: 191–205. 17. Rodeghiero F, Tosetto A, Abshire T, et al. ISTH BAT:Supplementary Material To the Official Communication of the SSC. Journal of Thrombosis and Haemostasis 2011; 8: 1–21. 18. Elbatarny M, Mollah S, Grabell J, et al. Normal range of bleeding scores for the ISTH-BAT: Adult and pediatric data from the merging project. Haemophilia 2014; 20: 831–5. 19. Tosetto A, Castaman G, Plug I, Rodeghiero F, Eikenboom J. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. Journal of Thrombosis and Haemostasis 2011; 9: 1143–8. 20. Lowe GC, Lordkipanidzé M, Watson SP. Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. Journal of Thrombosis and Haemostasis 2013; 11: 1663–8. 21. Deforest M, Grabell J, Albert S, et al. Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease. Haemophilia 2015; 21: e384–8. 22. Castellone DD. Establishing reference intervals in the coagulation laboratory. Int J Lab Hematol 2017; 39: 121–7. 23. CLSI. CLSI. (2008). Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition. CLSI document EP28-A3c. Wayne, PA: Clinical Laboratory Standards Institute. CLSI (2008) Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition CLSI document EP28-A3c Wayne, PA: Clinical Laboratory Standards Institute 2013. 24. Ozarda Y, Higgins V, Adeli K. Verification of reference intervals in routine clinical laboratories: Practical challenges and recommendations. Clin Chem Lab Med. 2019; 57. DOI:10.1515/ cclm-2018-0059. 25. den Dunnen JT, Dalgleish R, Maglott DR, et al. HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Hum Mutat 2016; 37. DOI:10.1002/humu.22981. 26. Schmider E, Ziegler M, Danay E, Beyer L, Bühner M. Is It Really Robust?: Reinvestigating the robustness of ANOVA against violations of the normal distribution assumption. Methodology 2010; 6: 147–51.
RkJQdWJsaXNoZXIy MTk4NDMw